Latest News and Press Releases

PharmAla files its final short form prospectus, and announces a signed term sheet with an R&D tax credit financing firm called Radium

PharmAla launches new web portal for MDMA prescribers and appoints a new COO

MAPS brings MDMA-assisted therapy training to Poland for the first time, awarding scholarships to 20 practitioners from war-affected Ukraine and Palestine.

Backed by Sam Altman, Fred Ehrsam, and Dylan Field, Arcadia Medicine is accelerating development of safe empathogens via patented, non-racemic MDMA

PharmAla completes first domestic US shipment of MDMA from its new domestic distribution center, and issues shares as debt payment.

ATMA CENA announce the expansion of its psychedelic therapy clinic network to 13 locations across Canada

TORONTO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and...

TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and...

PharmAla announces completion of onboarding for its US distribution centre and resignation of its Chief Operating Officer.

Psycan discloses troubling statistics showing that Health Canada has begun to deny numerous doctor requests for MDMA and Psilocybin